Recommendation from Healthcare Sector

This section gives a recommendation of a stock having stock price below Rs 150 with sound fundamentals and expected to give handsome returns over a one-year time horizon[EasyDNNnews:PaidContentStart]

KMC Speciality Hospitals (India) Ltd. : RIDING ON HEALTHCARE TAILWINDS

HERE IS WHY
✓  Maa Kauvery ramp-up may lift occupancy
✓  Speciality care demand remains strong
✓  Higher utilisation may aid margins

India’s healthcare market is shifting from basic treatment-led care to organised, specialised and outcome-led services. Rising health awareness, wider insurance cover and demand for quality care in Tier-II cities are creating a strong runway for regional hospital chains. High-value areas such as mother and child care, neuro, gastro, critical care and transplant services are gaining traction, as patients prefer trusted tertiary hospitals closer to home.

KMC Speciality Hospitals fits well into this shift as a Trichy-based multi-speciality healthcare player under the Kauvery brand. With 450 operational beds across two facilities, including the 200-bed Maa Kauvery unit focused on mother and child care, it has built a strong regional base. Its ability to draw patients from over 200 km, backed by advanced infrastructure and key specialities, places KMC as a focused tertiary care platform in Tamil Nadu.

The company has several medium-term growth levers. The key trigger is the ramp-up of the 200-bed Maa Kauvery facility, which can lift occupancy, patient volumes and operating leverage as utilisation improves. This is visible in the numbers. Occupied bed days rose 24 per cent YoY to 24,000 in Q4 FY26 from 19,380 in Q4 FY25, while average occupied beds increased to 267 from 215. Occupancy improved to 81 per cent from 65 per cent. In Q4 FY26, Outpatient Department (OPD) volumes grew 32 per cent YoY to 55,630, while Inpatient Department (IPD) volumes rose 17 per cent YoY to 4,823. Blended Average Revenue per Occupied Bed (ARPOB) improved 7 per cent YoY to ₹32,838. Demand across mother and child care, neurosciences, gastro sciences, critical care and transplant-related services should support revenue visibility. KMC’s focus on centres of excellence, doctor engagement and clinical talent retention can strengthen outcomes and referral flows.

The company is also investing in technology, digital enablement and process improvement, which can support patient experience, efficiency and margins. Backed by the wider Kauvery Hospital network, KMC is placed to scale profitably in Tamil Nadu’s organised healthcare market.

Key risks need to be watched. Healthcare is highly regulated and service-sensitive, and any lapse in clinical quality, patient safety or compliance can hurt reputation and performance. Rising input costs, shortage of medical supplies and availability of resources remain operational risks. A slower-than-expected ramp-up of the new facility may delay operating leverage benefits. Competition from hospital chains and the need to retain quality doctors are other monitorables.

Financially, KMC delivered a strong FY26 performance, led by higher patient volumes, improved occupancy and better realisation per bed. Revenue from operations rose 32 per cent YoY to ₹305.8 crore, while total income grew 32.5 per cent to ₹310.8 crore. Q4 FY26 was strong, with total income rising 36.3 per cent YoY to ₹84.2 crore. EBITDA grew 71 per cent YoY to ₹27.8 crore, with margin expanding to 33 per cent from 26.3 per cent. PAT jumped 224 per cent YoY to ₹14.6 crore, while PAT margin improved to 17.4 per cent, showing better cost absorption.

At the current valuation, KMC trades at a P/E ratio of 39.7x, below its 3-year median P/E of 46.9x. This offers valuation comfort, given its growth in revenue, margins and operating metrics. The outlook remains positive, supported by facility ramp-up, rising ARPOB, improving occupancy, higher patient volumes and favourable healthcare tailwinds. With strong regional positioning, specialised services and improving operating leverage, KMC appears well placed for sustained growth. Keeping the above factors in mind, we recommend a BUY on the stock.

[EasyDNNnews:PaidContentEnd] [EasyDNNnews:UnPaidContentStart]

[EasyDNNnews:UnPaidContentEnd]